Alpha-1-antitrypsin associated panniculitis: the MS variant

Journal of the American Academy of Dermatology
Pedram GeraminejadMarta VanBeek

Abstract

Over 90 mutant alleles of the alpha-1-antitrypsin (AAT) gene are recognized and classified by mobility on an acid starch gel. The four major categories include: F=fast, M=medium, S=slow, Z=very slow. Among 41 reported cases of AAT panniculitis, most have the ZZ phenotype with AAT levels below normal. We report two cases of AAT panniculitis with MS phenotype and normal AAT levels. In addition, we review the pathophysiology, epidemiology, and extracutaneous manifestations of AAT disease and propose a diagnostic algorithm for ulcerative panniculitis. A 42-year-old man presented with a solitary plaque on the left thigh exacerbated by trauma or excessive activity. The lesion frequently suppurated with a yellowish oily material. Twenty years before, he had fractured his left femur which was repaired with a metal plate. X-rays, histology with special stains for organisms, and cultures were negative. AAT phenotype was MS and AAT value was normal. A 43-year-old woman presented with multiple plaques on the proximal extremities which suppurated with exercise or trauma. AAT phenotype was MS and AAT level was normal. Histologic exam for both patients showed a dense neutrophilic infiltrate with septal and lobular panniculitis and areas of ne...Continue Reading

References

Jun 1, 1977·Annals of Internal Medicine·H M RubinsteinF R Schmid
Jan 1, 1991·Annals of the New York Academy of Sciences·S Eriksson
Oct 1, 1989·The American Review of Respiratory Disease·E K SilvermanE J Campbell
Jan 19, 1985·Lancet·E D JanusR W Carrell
Nov 1, 1988·Acta paediatrica Scandinavica·T Sveger
Apr 1, 1988·Journal of the American Academy of Dermatology·S J HendrickJ T Headington
Apr 1, 1986·Journal of the American Academy of Dermatology·R VirabenC Mathieu
Mar 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G C Newell
Jan 1, 1985·Archives of Dermatological Research·E Bleumink, A H Klokke
Mar 1, 1983·Archives of Dermatology·S M BreitR Penny
Nov 1, 1994·Mayo Clinic Proceedings·W I SchievinkU B Prakash
Aug 1, 1994·Journal of the American Academy of Dermatology·J D Geller, W P Su
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y WuD H Perlmutter
Mar 1, 1993·Clinical and Experimental Dermatology·A R PintoA F Freitas
Jul 1, 1997·American Journal of Respiratory and Critical Care Medicine·E EdenG M Turino
Mar 7, 1998·Scandinavian Journal of Gastroenterology·C FolwacznyH Fricke
May 15, 1998·The British Journal of Dermatology·M Linares-BarriosM Navarrete
Oct 17, 1998·Seminars in Liver Disease·D H Perlmutter
Jan 16, 1999·Baillière's Clinical Gastroenterology·S Eriksson, A N Elzouki
Jan 28, 1999·American Journal of Respiratory Cell and Molecular Biology·A J SandfordP D Paré
Apr 9, 1999·The Journal of Clinical Investigation·R MahadevaD A Lomas
Jan 5, 2000·American Journal of Respiratory and Critical Care Medicine·N SeersholmA Dirksen
Aug 5, 2000·The Journal of Biological Chemistry·P SivasothyD A Lomas
May 24, 2001·Medizinische Klinik·V Voigtländer, B Roberg
Dec 26, 2001·American Journal of Medical Genetics·L C LimaT R da Silveira
Dec 25, 2002·Journal of Molecular Biology·Dimitri GilisStephen P Bottomley

❮ Previous
Next ❯

Citations

Aug 24, 2010·Rheumatology International·Carlos D OchoaAntonio Iglesias-Gamarra
Nov 23, 2007·The American Journal of Dermatopathology·Pedram Gerami, Joan Guitart
Nov 15, 2011·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Michael R RingenbachFaoud T Ishmael
Jan 1, 2009·Case Reports in Medicine·Nicola W Mwirigi, Charles F Thomas
Feb 13, 2013·Journal of the American Academy of Dermatology·May P ChanRosalynn M Nazarian
Mar 17, 2012·Journal of the American Academy of Dermatology·Jonathan M OlsonJay C Vary
Sep 17, 2008·Dermatologic Clinics·Ricardo ValverdePablo L Ortiz-Romero
Sep 17, 2008·Dermatologic Clinics·Guillermo Guhl, Amaro García-Díez
Aug 7, 2008·Journal of Cutaneous Pathology·Cynthia M MagroArthur Neil Crowson
Jul 15, 2011·Journal of Cutaneous Pathology·Eugene B KirklandDavid Peng
Oct 6, 2007·The Journal of Veterinary Medical Science·Chie YamagishiToshiroh Iwasaki
Nov 26, 2015·The British Journal of Dermatology·I BlancoS Janciauskiene
Aug 16, 2016·Clinics in Chest Medicine·Umur Hatipoğlu, James K Stoller
May 18, 2017·Clinical and Experimental Dermatology·E R StoranT Markham
Feb 23, 2018·The American Journal of Dermatopathology·Mar Llamas VelascoMaría Teresa Fernández Figueras
May 1, 2018·International Journal of Dermatology·Emma F JohnsonLawrence E Gibson
Jul 18, 2021·Clinics in Dermatology·Iliana L Aguirre-Martinez, Antonio Torrelo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.